NRX Pharmaceuticals Inc (NRXP) — Defensive Interval Ratio
NRX Pharmaceuticals Inc (NRXP) has a Defensive Interval Ratio of 2 days as of September 2025. Defensive assets of $239.00K (cash $-, short-term investments $-, receivables $239.00K) cover 2 days of daily cash needs of $111.21K/day. See NRXP working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
NRX Pharmaceuticals Inc Defensive Interval Ratio (2017–2023)
This chart shows how NRX Pharmaceuticals Inc's Defensive Interval Ratio has evolved across 7 annual periods from 2017 to 2023. As of September 2025, the ratio stands at 2 days, meaning defensive assets of $239.00K can fund 2 days of operations without new revenue. See debt-free asset ratio of NRX Pharmaceuticals Inc to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for NRX Pharmaceuticals Inc (2017–2023)
The table below presents the year-by-year Defensive Interval Ratio for NRX Pharmaceuticals Inc from 2017 to 2023, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see NRX Pharmaceuticals Inc market cap and net worth.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2023 | 0 days | $6.00K | $52.19K/day | $- | $- | ▼ 0 days |
| 2022 | 0 days | $7.00K | $42.70K/day | $- | $- | ▲ +0 days |
| 2021 | 0 days | $0.00 | $32.67K/day | $- | $- | ▼ -54 days |
| 2020 | 54 days | $6.80 Million | $126.48K/day | $- | $5.97 Million | ▼ -18714 days |
| 2019 | 18768 days | $32.01 Million | $1.71K/day | $- | $32.01 Million | ▼ -26754 days |
| 2018 | 45522 days | $70.77 Million | $1.55K/day | $- | $70.77 Million | ▼ -224903 days |
| 2017 | 270425 days | $69.03 Million | $255.26/day | $- | $69.03 Million | — |